 |
AIDSinfo E-News: Offering HIV/AIDS Research, Clinical Trials, Prevention, and Treatment Information. |
|
AIDSinfo At-a-Glance Issue No. 23July 22, 2005 AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful. Interleukin-2 Extends Life of Key T Cells Interleukin-2
(IL-2), an immune-boosting drug used experimentally in HIV therapy, has been
found to greatly increase the lifespan of T cells in some HIV-positive people.
This is significant news for people living with HIV/AIDS. A
steady loss of CD4 T cells is a characteristic of HIV infection. This loss of T
cells compromises and can prevent an HIV-infected person's ability to fend off
disease. Read the full story: http://www.nih.gov/news/pr/jul2005/cc-14.htm.
To read more about IL-2 click here: http://www.aidsinfo.nih.gov/drugs/htmldrug_nt.asp?int_id=0021. “Front-Line
HIV Care Providers, This Is For You!” — Dr. Lawrence Deyton,
M.D., Chief of Public Health for the U.S. Department of Veterans Affairs Ten Federal health
agencies will come together to host the first annual Treatment and Management
of HIV Conference in Atlanta, Georgia, September 15–18, 2005. This
state-of-the-science conference is intended for front-line health care
providers who want the latest treatment information and the chance to network
with other doctors, nurses, physician’s assistants, nurse practitioners,
pharmacists, psychologists, and social workers caring for people with HIV/AIDS.
Topics include new models of care and delivery, adherence interventions, and
testing, and counseling. For more information about this conference, go to: www.ushivconference.org. ClinicalTrials.gov Info Please send comments or
suggestions to ContactUs@aidsinfo.nih.gov
|
|
|
|
You are currently subscribed to %%list.name%% as:
%%emailaddr%% Subscribe to AIDSinfo list serv here. |
|
Contact AIDSinfo Click on the Live Help button on the AIDSinfo home page and communicate with the staff in “real time.” |